1,021 filings
Page 4 of 52
425
LSTA
Lisata Therapeutics Inc
2 Sep 22
Business combination disclosure
4:01pm
8-K
LSTA
Lisata Therapeutics Inc
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
425
LSTA
Lisata Therapeutics Inc
15 Aug 22
Business combination disclosure
6:46am
425
LSTA
Lisata Therapeutics Inc
10 Aug 22
Business combination disclosure
8:08am
8-K
LSTA
Lisata Therapeutics Inc
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
10-Q
2022 Q2
LSTA
Lisata Therapeutics Inc
Quarterly report
4 Aug 22
4:44pm
424B3
LSTA
Lisata Therapeutics Inc
29 Jul 22
Prospectus supplement
4:06pm
EFFECT
LSTA
Lisata Therapeutics Inc
29 Jul 22
Notice of effectiveness
12:15am
S-4/A
LSTA
Lisata Therapeutics Inc
Registration of securities issued in business combination transactions (amended)
26 Jul 22
4:45pm
CORRESP
LSTA
Lisata Therapeutics Inc
26 Jul 22
Correspondence with SEC
12:00am
425
LSTA
Lisata Therapeutics Inc
6 Jul 22
Business combination disclosure
4:05pm
S-4
LSTA
Lisata Therapeutics Inc
Registration of securities issued in business combination transactions
15 Jun 22
5:06pm
425
LSTA
Lisata Therapeutics Inc
9 Jun 22
Business combination disclosure
4:01pm
8-K
LSTA
Lisata Therapeutics Inc
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
LSTA
Lisata Therapeutics Inc
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
10-Q
2022 Q1
LSTA
Lisata Therapeutics Inc
Quarterly report
5 May 22
12:00am
425
LSTA
Lisata Therapeutics Inc
27 Apr 22
Business combination disclosure
5:26pm
8-K
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
10-K/A
2021 FY
LSTA
Lisata Therapeutics Inc
Annual report (amended)
21 Apr 22
4:04pm
10-K
2021 FY
LSTA
Lisata Therapeutics Inc
Annual report
22 Mar 22
4:10pm